Metabolomic analysis by 1H-nuclear magnetic resonance spectroscopy suggest that there are 2 phenotypes of human hepatocellular carcinoma developed in non-alcoholic fatty liver disease according to fibrosis level (F0F1 vs F3F4)

Camille Teilhet (1, 2) , Christelle Reynes (3, 4, 5) , Robert Sabatier (3, 4, 5) , Anne-Sophie Martin Biesse (6) , Marie-Paule Vasson (1) , Armand Abergel (7, 8, 9, 10, 2) , Aïcha Demidem (1)

1 UNH - Unité de Nutrition Humaine
2 Hépatologie Gastro-Entérologie
3 IGF - Institut de Génomique Fonctionnelle
4 UM - Université de Montpellier
5 FPHM - Faculté de Pharmacie [Monastir]
6 ICCF - Institut de Chimie de Clermont-Ferrand
7 IP - Institut Pascal
8 UCA [2017-2020] - Université Clermont Auvergne [2017-2020]
9 CNRS - Centre National de la Recherche Scientifique
10 SIGMA Clermont

Metabolomic analysis by 1H-nuclear magnetic resonance spectroscopy suggest that there are 2 phenotypes of human hepatocellular carcinoma developed in non-alcoholic fatty liver disease according to fibrosis level (F0F1 vs F3F4). International Liver Congress

Domaines: Hépatologie et Gastroentérologie

Camille Teilhet, Christelle Reynes, Robert Sabatier, Anne-Sophie Martin Biesse, Marie-Paule Vasson, et al.. Metabolomic analysis by 1H-nuclear magnetic resonance spectroscopy suggest that there are 2 phenotypes of human hepatocellular carcinoma developed in non-alcoholic fatty liver disease according to fibrosis level (F0F1 vs F3F4). International Liver Congress, Apr 2019, Vienne, Austria. ⟨10.1016/S0618-8278(19)30702-9⟩. ⟨hal-02124773⟩